AccessDx Laboratory is a biotechnology and healthcare startup founded in 2016, headquartered in Houston, TX. The company's slogan, "AccessDx — dedicated to enhancing and extending patients’ lives," reflects its core mission of optimizing patient therapy. AccessDx is at the forefront of precision medicine and aims to make healthcare safer and more effective for every patient through personalized medicine at an affordable cost. The company provides clinical insights that improve patient outcomes by offering integrated genomic solutions. These solutions equip physicians with actionable intelligence, enabling them to make more informed therapy decisions. AccessDx redefines the patient journey by incorporating diagnostics such as pharmacogenomics and therapeutic drug monitoring into its proprietary solutions. Notably, AccessDx is licensed to run tests in all 50 states including New York, California, and other U.S. territories like Puerto Rico. This broad regulatory approval enhances the company's potential reach and impact. Despite the lack of specific details on its last investment and investors, AccessDx Laboratory demonstrates a strong commitment to advancing precision medicine and improving patient outcomes, positioning it as an intriguing prospect for potential investors in the biotechnology and healthcare sectors.
There is no investment information
No recent news or press coverage available for AccessDx Laboratory.